Business Standard
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap (    %)
                             
Nifty Smallcap (    %)
                             
Nifty Bank (    %)
                             
Home / Markets / Coral Laboratories Ltd

Coral Laboratories Share Price

Know More
BSENSE

₹793.65-6.35 (-0.79%)

13-Dec-2024
Stock not traded

BSE : 524506

NSE :

Sector : Health care

ISIN Code : INE683E01017

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 13-Dec-2024

Add to PortfolioAdd to Watchlist

Market Cap (₹ Cr)

283

Traded Value (₹ Cr)

0.08

Volume (Shares)

952

Face Value (₹)

10

52-Week High (₹)

999.00

52-Week High Date

12-Sep-2024

52-Week Low (₹)

344.90

52-Week Low Date

29-Feb-2024

All Time High (₹)

1,190.00

All Time High Date

25-Jul-2017

All Time Low (₹)

7.25

All Time Low Date

10-Jul-2001

Coral Laboratories Ltd

Coral Laboratories Limited (CLL) was established in February 1997. Carol Labs are into manufacturing of Generic Branded Nutraceuticals OTC and Herbal Medicines. The Company produces various pharmaceutical formulations in 3 different locations all over India. It has plants at Daman and Dehradun . The Company was promoted by Navin B Doshi of the DWD group. To manufacture pharmaceutical formulations like tablets capsules liquid and topical preparation the Company went into public issue in March 94 at a total cost of Rs.2.5 crores. It setup an additional ultra-modern manufacturing unit at Daman and the said Unit started the commercial production during March 2004. It started the commercial produ...
Read More

Market News

Sebi enacts significant changes to disclosure and RPT regulations

3 min read

FPIs return to equities; infuse Rs 22,766 cr in first two weeks of Dec

3 min read

Mcap of 5 of top-10 most valued firms climb to Rs 1.13 trn; Airtel shines

2 min read

Mkts to be guided by US Fed rate decision, WPI inflation, trends: Analysts

2 min read

Eleganz Interiors files draft papers with NSE Emerge to raise funds via IPO

2 min read
More

Coral Labs. Announcement

Submission of Limited Review Report missed inadvertently in financial result submitted on 14th November 2024

Pursuant to Regulation 33 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed copies of newspaper advertisement pertaining to Standalone Unaudited standalone financial results of the Company for the quarter and half year ended September 30 2024 published in following English and Regional (Marathi) Newspapers: -1. Financial Express (English) (16.11.2024)2. Mumbai Lakshadeep (Marathi) (16.11.2024)

Dear Sir/MadamSub: Disclosure under Reg 23(9) of SEBI (LODR) Regulations 2015Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby submit disclosure of Related Party Transactions for the half year ended September 30 2024 in accordance with the applicable Accounting Standards.This is for your information and record.

Pursuant Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclosed herewith following: 1. The Unaudited Standalone Financial Results of the Company for the quarter and half year ended September 30 2024.2. Limited Review Report thereon.3. Statement of Asset & Liabilities for the half year ended September 302024.4. Cash Flow Statements for the half year ended September 302024.

In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and other applicable provisions the Board of Directors of the Company in its meeting held on Thursday 14th November 2024 at the Corporate Office of the Company situated at 3B Patanwala Compound Opp. Shreyas Cinema L.B.S. Marg Ghatkopar (W) Mumbai- 400086 at 2:30 P.M has inter alia considered and approved: 1. The Unaudited Standalone Financial Results along with Statement of Asset & Liabilities and Cash Flow Statement for the quarter and half year ended September 30 2024 and took note of the Limited Review Report submitted by M A Parekh & Associates Statutory Auditor of the Company.

More

Coral Laboratories Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

283

EPS - TTM (₹) [S]

65.12

P/E Ratio (X) [S]

12.19

Face Value (₹) 10
Latest Dividend (%)20.00
Latest Dividend Date 20-Sep-2024
Dividend Yield (%) -
Book Value Share (₹) [S]570.15
P/B Ratio (₹) [S]1.39

[*C] Consolidated [*S] Standalone

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

792.05

823.00

Week Low/High (₹)

756.00

858.00

Month Low/High (₹)

736.90

889.00

Year Low/High (₹)

344.90

999.00

All time Low/High (₹)

7.25

1,190.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-2.48%%0.520.37%
1 Month-6.11%%5.725.13%
3 Month-17.78%%-0.91-2.32%
6 Month33.90%%6.935.85%
1 Year82.62%%18.0318.36%
3 Year183.85%%40.9242.61%

Company Info

Company Information

Whole-time Director : Girish Dhameja

Director & CFO : Sushma Shashi Kadkade

Independent Director : Saurabh Shah

Independent Director : Malay Doshi

Non Executive Director : Rajendrasinh Rana

Company Sec. & Compli. Officer : Dhwani Desai

Independent Director : Pooja Hindia

Registered Office: SF-206 Silver Oak Complex, BPC Road,Vadodara,Gujarat-390020 Ph: 91-022-2500 5245/46

Email:cs@corallab.com

URL:http://www.corallab.com

FAQs about Coral Laboratories Ltd

1. What's the Coral Laboratories Ltd share price today?
Coral Laboratories Ltd share price was Rs 793.65 at close on 13th Dec 2024. Coral Laboratories Ltd share price was down by 0.79% from the previous closing price of Rs 800.00. Coral Laboratories Ltd share price trend:

  • Last 1 Month: Coral Laboratories Ltd share price moved down by 6.11% on BSE
  • Last 3 Months: Coral Laboratories Ltd share price moved down by 17.78% on BSE
  • Last 12 Months: Coral Laboratories Ltd share price moved up by 82.62% on BSE
  • Last 3 Years: Coral Laboratories Ltd price moved up by 183.85% on BSE


2. How can I quickly analyse the performance of the Coral Laboratories Ltd stock?
The performance of the Coral Laboratories Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 12.19
  • Price to book value ratio is 1.39
  • Dividend yield of 0.00
  • The EPS (trailing 12 months) of the Coral Laboratories Ltd stock is Rs 65.12


3. What is the market cap of Coral Laboratories Ltd?
Coral Laboratories Ltd has a market capitalisation of Rs 283 crore.


4. What is Coral Laboratories Ltd's 52-week high/low share price?
The Coral Laboratories Ltd’s 52-week high share price is Rs 999.00 and 52-week low share price is Rs 344.90.


5. Is the Coral Laboratories Ltd profitable?
On a consolidated basis, Coral Laboratories Ltd reported a profit of Rs 6.38 crore on a total income of Rs 34.77 crore for the quarter ended 2024. For the year ended Sep 2024, Coral Laboratories Ltd had posted a profit of Rs 6.38 crore on a total income of Rs 34.77 crore.


6. Which are Coral Laboratories Ltd’s peers in the Health care sector?
Coral Laboratories Ltd’s top 5 peers in the Health care sector are Shukra Pharma., Natural Capsules, Panch.Organics, Coral Labs., Alpa Laboratorie, Krebs Biochem, Denis Chem Lab.


7. Who owns how much in Coral Laboratories Ltd?
Key changes to the Coral Laboratories Ltd shareholding are as follows:

  • Promoter holding in Coral Laboratories Ltd has gone up to 71.51 per cent as of Sep 2024 from 71.51 per cent as of Dec 2023.

HOT STOCKS
TOP SECTIONS
KEY EVENTS
Copyrights © 2024 Business Standard Private Ltd. All rights reserved
LinkedIN Icon